Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank27
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-44.60M
↓ 50% vs avg
Percentile
P27
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-29.76M
Historical baseline
PeriodValueYoY Change
TTM$-44.60M+13.2%
2025$-51.41M+2.8%
2024$-52.88M+5.2%
2023$-55.76M-9.4%
2022$-50.99M-21.4%
2021$-42.00M-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-